Chemopreventive effect of 4'‑hydroxychalcone on intestinal tumorigenesis in ApcMin mice Corrigendum in /10.3892/ol.2021.12741

Chen,Qing; Lei,Jiahong; Zhou,Jinzhe; Ma,Shaoze; Huang,Qi; Ge,Bujun

doi:10.3892/ol.2021.12474

Chemopreventive effect of 4'‑hydroxychalcone on intestinal tumorigenesis in ApcMin mice

Corrigendum in: /10.3892/ol.2021.12741

Authors:
- Qing Chen
- Jiahong Lei
- Jinzhe Zhou
- Shaoze Ma
- Qi Huang
- Bujun Ge
View Affiliations

Affiliations: Department of General Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Department of Pediatrics, State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of General Surgery, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, P.R. China
Published online on: January 18, 2021 https://doi.org/10.3892/ol.2021.12474
Article Number: 213
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chalcones and its derivatives are reported to exhibit anti‑cancer effects in several cancer cell lines, including colon cancer cells. However, the in vivo anticancer effects and associated mechanisms of chalcones against intestinal tumorigenesis currently remain unclear. The aim of the present study was to investigate the chemopreventive effect of a chalcone derivative, 4'‑hydroxychalcone (4‑HC), in a transgenic adenomatous polyposis coli multiple intestinal neoplasia mouse model (Apc^Min) of spontaneous intestinal adenomas. Apc^Min mice were fed 4‑HC (10 mg/kg/day) or the vehicle control by oral gavage starting at 8 weeks of age, and were sacrificed at 20 weeks. The administration of 4‑HC significantly decreased the number of colon adenomas by 45% and the size of colon adenomas by 35% compared with the respective controls. Similarly, the number of adenomas in the distal small intestine (DSI) and proximal small intestine also decreased by 35 and 33%, respectively, in 4‑HC‑treated mice, and adenoma size in the DSI decreased by 39% compared with the respective controls. Treatment with 4‑HC strongly decreased proliferation in colon and DSI adenomas, as detected by immunofluorescence staining with the proliferation marker protein Ki‑67, and promoted apoptosis in colon adenomas, as detected by TUNEL immunofluorescence staining. In addition, decreased mRNA expression of β‑catenin target genes, including c‑Myc, Axin2 and CD44, in colon adenomas of 4‑HC‑treated animals demonstrated the involvement of the Wnt/β‑catenin signaling pathway in the initiation and progression of colon neoplasms. Treatment with 4‑HC also decreased the protein levels of β‑catenin in colon adenomas, as demonstrated by immunofluorescence staining. The results suggested that 4‑HC may be a promising candidate for the chemoprevention of intestinal tumorigenesis, and further investigations are required to evaluate its clinical utility.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
2	Hofseth LJ, Hebert JR, Chanda A, Chen H, Love BL, Pena MM, Murphy EA, Sajish M, Sheth A, Buckhaults PJ and Berger FG: Early-onset colorectal cancer: Initial clues and current views. Nat Rev Gastroenterol Hepatol. 17:352–364. 2020. View Article : Google Scholar : PubMed/NCBI
3	Grady WM and Carethers JM: Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 135:1079–1099. 2008. View Article : Google Scholar : PubMed/NCBI
4	Rubinfeld B, Souza B, Albert I, Müller O, Chamberlain SH, Masiarz FR, Munemitsu S and Polakis P: Association of the APC gene product with beta-catenin. Science. 262:1731–1734. 1993. View Article : Google Scholar : PubMed/NCBI
5	Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B and Kinzler KW: APC mutations occur early during colorectal tumorigenesis. Nature. 359:235–237. 1992. View Article : Google Scholar : PubMed/NCBI
6	Roose J and Clevers H: TCF transcription factors: Molecular switches in carcinogenesis. Biochim Biophys Acta. 1424:M23–M37. 1999.PubMed/NCBI
7	Stamos JL and Weis WI: The β-catenin destruction complex. Cold Spring Harb Perspect Biol. 5:a0078982013. View Article : Google Scholar : PubMed/NCBI
8	Moser AR, Luongo C, Gould KA, McNeley MK, Shoemaker AR and Dove WF: ApcMin: A mouse model for intestinal and mammary tumorigenesis. Eur J Cancer. 31A:1061–1064. 1995. View Article : Google Scholar : PubMed/NCBI
9	Corpet DE and Pierre F: Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the mod'el system. Cancer Epidemiol Biomarkers Prev. 12:391–400. 2003.PubMed/NCBI
10	Aune D, Giovannucci E, Boffetta P, Fadnes LT, Keum N, Norat T, Greenwood DC, Riboli E, Vatten LJ and Tonstad S: Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies. Int J Epidemiol. 46:1029–1056. 2017. View Article : Google Scholar : PubMed/NCBI
11	Luo WP, Fang YJ, Lu MS, Zhong X, Then YM and Zhang CX: High consumption of vegetable and fruit colour groups is inversely associated with the risk of colorectal cancer: A case-control study. Br J Nutr. 113:1129–1138. 2015. View Article : Google Scholar : PubMed/NCBI
12	O'Keefe SJ: Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol. 13:691–706. 2016. View Article : Google Scholar : PubMed/NCBI
13	Yang K, Lamprecht SA, Liu Y, Shinozaki H, Fan K, Leung D, Newmark H, Steele VE, Kelloff GJ and Lipkin M: Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis. 21:1655–1660. 2000. View Article : Google Scholar : PubMed/NCBI
14	Du WJ, Yang XL, Song ZJ, Wang JY, Zhang WJ, He X, Zhang RQ, Zhang CF, Li F, Yu CH, et al: Antitumor Activity of total flavonoids from daphne genkwa in colorectal cancer. Phytother Res. 30:323–330. 2016. View Article : Google Scholar : PubMed/NCBI
15	Chang H, Lei L, Zhou Y, Ye F and Zhao G: Dietary flavonoids and the risk of colorectal cancer: An updated Meta-analysis of epidemiological studies. Nutrients. 10:9502018. View Article : Google Scholar
16	Cho YA, Lee J, Oh JH, Chang HJ, Sohn DK, Shin A and Kim J: Dietary flavonoids, CYP1A1 genetic variants, and the risk of colorectal cancer in a korean population. Sci Rep. 7:1282017. View Article : Google Scholar : PubMed/NCBI
17	Zamora-Ros R, Not C, Guinó E, Luján-Barroso L, García RM, Biondo S, Salazar R and Moreno V: Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study). Cancer Causes Control. 24:549–557. 2013. View Article : Google Scholar : PubMed/NCBI
18	Hsieh CT, Hsieh TJ, El-Shazly M, Chuang DW, Tsai YH, Yen CT, Wu SF, Wu YC and Chang F: Synthesis of chalcone derivatives as potential anti-diabetic agents. Bioorg Med Chem Lett. 22:3912–3915. 2012. View Article : Google Scholar : PubMed/NCBI
19	Mirossay L, Varinska L and Mojzis J: Antiangiogenic effect of flavonoids and chalcones: An update. Int J Mol Sci. 19:272017. View Article : Google Scholar
20	Fernandes I, Pérez-Gregorio R, Soares S, Mateus N and de Freitas V: Wine flavonoids in health and disease prevention. Molecules. 22:2922017. View Article : Google Scholar
21	Kar Mahapatra D, Asati V and Bharti SK: An updated patent review of therapeutic applications of chalcone derivatives (2014-present). Expert Opin Ther Pat. 29:385–406. 2019. View Article : Google Scholar : PubMed/NCBI
22	Mahapatra DK, Bharti SK and Asati V: Anti-cancer chalcones: Structural and molecular target perspectives. Eur J Med Chem. 98:69–114. 2015. View Article : Google Scholar : PubMed/NCBI
23	Karthikeyan C, Moorthy NS, Ramasamy S, Vanam U, Manivannan E, Karunagaran D and Trivedi P: Advances in chalcones with anticancer activities. Recent Pat Anticancer Drug Discov. 10:97–115. 2015. View Article : Google Scholar : PubMed/NCBI
24	Kim HG, Oh HJ, Ko JH, Song HS, Lee YG, Kang SC, Lee DY and Baek NI: Lanceoleins A-G, hydroxychalcones, from the flowers of Coreopsis lanceolata and their chemopreventive effects against human colon cancer cells. Bioorg Chem. 85:274–281. 2019. View Article : Google Scholar : PubMed/NCBI
25	Shin S, Son Y, Liu KH, Kang W and Oh S: Cytotoxic activity of broussochalcone a against colon and liver cancer cells by promoting destruction complex-independent β-catenin degradation. Food Chem Toxicol. 131:1105502019. View Article : Google Scholar : PubMed/NCBI
26	Kello M, Drutovic D, Pilatova MB, Tischlerova V, Perjesi P and Mojzis J: Chalcone derivatives cause accumulation of colon cancer cells in the G2/M phase and induce apoptosis. Life Sci. 150:32–38. 2016. View Article : Google Scholar : PubMed/NCBI
27	Loa J, Chow P and Zhang K: Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells. Cancer Chemother Pharmacol. 63:1007–1016. 2009. View Article : Google Scholar : PubMed/NCBI
28	Qu Q, Dai B, Yang B, Li X, Liu Y and Zhang F: 4-Hydroxychalcone attenuates hyperaldosteronism, inflammation, and renal injury in cryptochrome-null mice. Biomed Res Int. 2014:6034152014. View Article : Google Scholar : PubMed/NCBI
29	Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et al: Fiji: An open-source platform for biological-image analysis. Nat Methods. 9:676–682. 2012. View Article : Google Scholar : PubMed/NCBI
30	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
31	Polakis P, Hart M and Rubinfeld B: Defects in the regulation of beta-catenin in colorectal cancer. Adv Exp Med Biol. 470:23–32. 1999. View Article : Google Scholar : PubMed/NCBI
32	Fonseca BF, Predes D, Cerqueira DM, Reis AH, Amado NG, Cayres MC, Kuster RM, Oliveira FL, Mendes FA and Abreu JG: Derricin and derricidin inhibit Wnt/β-catenin signaling and suppress colon cancer cell growth in vitro. PLoS One. 10:e01209192015. View Article : Google Scholar : PubMed/NCBI
33	Hou G, Yuan X, Li Y, Hou G and Liu X: Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway. Invest New Drugs. 38:329–339. 2019. View Article : Google Scholar : PubMed/NCBI
34	Predes D, Oliveira LFS, Ferreira LSS, Maia LA, Delou JMA, Faletti A, Oliveira I, Amado NG, Reis AH, Fraga CAM, et al: The chalcone lonchocarpin inhibits wnt/beta-catenin signaling and suppresses colorectal cancer proliferation. Cancers (Basel). 11:19682019. View Article : Google Scholar
35	Yin L, Niu C, Liao LX, Dou J, Habasi M and Aisa HA: An isoxazole chalcone derivative enhances melanogenesis in B16 melanoma cells via the Akt/GSK3β/β-catenin signaling pathways. Molecules. 22:20772017. View Article : Google Scholar
36	Brenner H, Kloor M and Pox CP: Colorectal cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
37	Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV and Reddy BS: Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 59:597–601. 1999.PubMed/NCBI
38	Charepalli V, Reddivari L, Vadde R, Walia S, Radhakrishnan S and Vanamala JK: Eugenia jambolana (Java Plum) fruit extract exhibits anti-cancer activity against early stage human HCT-116 colon cancer cells and colon cancer stem cells. Cancers (Basel). 8:292016. View Article : Google Scholar
39	Mazewski C, Liang K and Gonzalez de Mejia E: Comparison of the effect of chemical composition of anthocyanin-rich plant extracts on colon cancer cell proliferation and their potential mechanism of action using in vitro, in silico, and biochemical assays. Food Chem. 242:378–388. 2018. View Article : Google Scholar : PubMed/NCBI
40	Wang W, Heideman L, Chung CS, Pelling JC, Koehler KJ and Birt DF: Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog. 28:102–110. 2000. View Article : Google Scholar : PubMed/NCBI
41	Banerjee K and Mandal M: Oxidative stress triggered by naturally occurring flavone apigenin results in senescence and chemotherapeutic effect in human colorectal cancer cells. Redox Biol. 5:153–162. 2015. View Article : Google Scholar : PubMed/NCBI
42	Xu S, Chen M, Chen W, Hui J, Ji J, Hu S, Zhou J, Wang Y and Liang G: Chemopreventive effect of chalcone derivative, L2H17, in colon cancer development. BMC Cancer. 15:8702015. View Article : Google Scholar : PubMed/NCBI
43	MacDonald BT, Tamai K and He X: Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
44	Kaemmerer E, Jeon MK, Berndt A, Liedtke C and Gassler N: Targeting wnt signaling via notch in intestinal carcinogenesis. Cancers (Basel). 11:5552019. View Article : Google Scholar
45	Krausova M and Korinek V: Wnt signaling in adult intestinal stem cells and cancer. Cell Signal. 26:570–579. 2014. View Article : Google Scholar : PubMed/NCBI
46	Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:422–426. 1999. View Article : Google Scholar : PubMed/NCBI
47	Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H and Pals ST: Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol. 154:515–523. 1999. View Article : Google Scholar : PubMed/NCBI
48	Lin CM, Chen HH, Lin CA, Wu HC, Sheu JJ and Chen HJ: Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling. Sci Rep. 7:3722017. View Article : Google Scholar : PubMed/NCBI
49	Park CH, Chang JY, Hahm ER, Park S, Kim HK and Yang CH: Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun. 328:227–234. 2005. View Article : Google Scholar : PubMed/NCBI
50	Cassidy A and Minihane AM: The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Am J Clin Nutr. 105:10–22. 2017. View Article : Google Scholar : PubMed/NCBI
51	Murota K, Nakamura Y and Uehara M: Flavonoid metabolism: The interaction of metabolites and gut microbiota. Biosci Biotechnol Biochem. 82:600–610. 2018. View Article : Google Scholar : PubMed/NCBI